subscribeSubscribe
Mundipharma, Vectura To Reformulate Flutiform® For Lower Emissions

Mundipharma, Vectura To Reformulate Flutiform® For Lower Emissions
BUSINESSWIRE
16 Apr 2024
Share Share
GSK to cap out-of-pocket inhaler costs in US

GSK to cap out-of-pocket inhaler costs in US
REUTERS
21 Mar 2024
Share Share
XHANCE Approved by FDA as First and Only Medication for Chronic Rhinosinusitis

XHANCE Approved by FDA as First and Only Medication for Chronic Rhinosinusitis
GLOBENEWSWIRE
16 Mar 2024
Share Share
Enforcement Report - Week of February 28, 2024

Enforcement Report - Week of February 28, 2024
FDA
28 Feb 2024
Share Share
GSK to cut US prices for Advair, Valtrex and Lamictal

GSK to cut US prices for Advair, Valtrex and Lamictal
REUTERS
23 Dec 2023
Share Share
GSK looks to authorized generic version of asthma treatment

GSK looks to authorized generic version of asthma treatment
Lia DeGroot ENDPTS
12 Oct 2023
Share Share
Enforcement Report - Week of June 7, 2023

Enforcement Report - Week of June 7, 2023
FDA
07 Jun 2023
Share Share
FDA accepts sNDA for Optinose’s XHANCE

FDA accepts sNDA for Optinose’s XHANCE
Betsy Goodfellow PHARMAFILE
05 May 2023
Share Share
Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion

Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion
GLOBENEWSWIRE
21 Feb 2023
Share Share
Drugmakers benefit `substantially` from secondary patents on inhalers — study

Drugmakers benefit `substantially` from secondary patents on inhalers — study
Nicole DeFeudis ENDPTS
03 Jan 2023
Share Share